Understand the source comparison
Reported Benefits vs Proven Benefits
You probably want a plain list of what this peptide is supposed to do. Almost every claim below comes from Russian in vitro, animal, or small clinical work. Read the list as "here is what the literature reports," not "here is what science has proven." Immune m
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- You probably want a plain list of what this peptide is supposed to do. Almost every claim below comes from Russian in vitro, animal, or small clinical work. Read the list as "here is what the literature reports," not "here is what science has proven."
- Immune modulation. The headline claim is that Vilon supports a tired immune system, in particular the thymus, which shrinks with age. The reported human study described shifts in immune markers in older patients (Adv Gerontol, 2007). This is a small, single-center result, not a validated immune therapy.
- Coagulation effects. The same study reported changes in blood-clotting parameters across age groups. That is an interesting signal and also a caution, because anything that touches clotting deserves respect, especially in older people already on blood thinners.
- General anti-aging positioning. Russian researchers often discuss Vilon inside a stack, on the theory that immune, pineal, and other systems age together. This is a framework, not a demonstrated outcome.
- What Vilon is not. It is not a proven treatment for immune deficiency, infection, cancer, or any diagnosed disease. No approved indication exists. If you have a diagnosed condition, your prescribed care stays put, and Vilon is at best an experimental add-on you discuss with a physician. If you are new to this class, the getting started with peptides guide sets realistic expectations before you buy anything.